Hetero Healthcare

What Hetero Healthcare does

Hetero Healthcare Limited is an Indian privately held pharmaceutical manufacturer headquartered in Madhapur, Hyderabad, with manufacturing operations in Guwahati and Kamrup (Assam), an R&D facility in Jeedimetla, and a marketing office in Mumbai. The company develops and markets 600+ formulation products spanning prescription pharmaceuticals across oncology, antiretroviral (ARV) drugs, rheumatology, gastroenterology, immunosuppressants, women's health, and dermatology, alongside OTC wellness lines including the bbold women's wellness brand and DaSutra sexual wellness products. Technical capabilities include proprietary transdermal patch technology, novel drug-device combination products such as Silero (claimed as the world's first lactic acid vaginal film), and ongoing R&D into oncology and ARV candidates derived from plant-based sources.

The company operates a B2B2C go-to-market model through a 4,000+ field force reaching 354,000+ doctors across India, with products distributed through pharmacy and medical store retail channels. Revenue is generated from one-time product sales across prescription and OTC categories, with pricing not publicly disclosed. Hetero Healthcare operates through specialized divisions including Bliss (patient education), Dermaglow (dermatology), ASRA (rheumatology), Volga (nephrology), and Ultra (OTC/sexual wellness), supplemented by digital initiatives Vidhita and Radiance targeting direct consumer engagement. The company is part of the broader Hetero Group and claims presence in 80+ international markets, producing 2.3 billion doses in 2023. Notable regulatory exposure includes a settled US patent litigation via Hetero USA and a historical class-action settlement over contaminated sartan-class medications.

Name

Hetero Healthcare

Legal name

Hetero Healthcare Limited

Website

https://heterohealthcare.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Hetero Healthcare Limited is an Indian generic pharmaceutical manufacturer producing 600+ prescription and OTC formulations across oncology, ARV, rheumatology, women's health, and dermatology, reaching 354,000+ doctors via a 4,000+ field force in India.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

• Generic pharmaceuticals
• Oncology drugs
• ARV medications
• OTC wellness products
• Formulation development

Headquarters

HQ city

Madhapur

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Pharmaceutical Products Sales: Hetero Healthcare generates revenue through the manufacture and sale of generic pharmaceutical products including OTC medicines, prescription drugs, and specialized therapeutic formulations across multiple divisions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Hetero Healthcare manufactures and sells a wide range of branded and non-branded generic pharmaceutical products including prescription medications, OTC medicines, and wellness products across multiple therapeutic areas such as oncology, ARV drugs, dermatology, rheumatology, women's health, gastroenterology, and sexual wellness. The company also provides formulation development services including R&D, scale-up batches, bio-studies, clinical studies, stability testing, and commercial production through its dedicated R&D facility in Hyderabad.

Product overview

Hetero Healthcare is an innovative Indian pharmaceutical company offering a diverse portfolio of prescription medications, OTC products, and wellness solutions across multiple therapeutic areas. The company operates through specialized divisions including Bliss (patient education), Dermaglow (dermatology), ASRA (rheumatology), AURA, Volga, Diaspa, and Ultra (OTC and sexual wellness). Core prescription products span oncology (chemotherapy agents like Pazinib, Ninlib, Dyronib, Maball-RA), anti-virals (HIV medications like Taffic, Tenof, Arvirm, COVID-19 treatments Covifor, Movfor), rheumatology (Methotrexate brands Methora, Maball-Ra, Jakura, SZN), women's health (Silero vaginal film, Secnia probiotic, Mylotin PCOS supplement, Feminora gel, Dydropal dydrogesterone, Prega End pregnancy termination), gastroenterology (Mesarem mesalamine for ulcerative colitis), and immunosuppressants (Mycotero). The bbold sub-brand covers women's wellness (menstrual cups, intimate wash, acne patches, pain relief patches), while Ultra Division handles sexual wellness (DaSutra erectile dysfunction products, condoms). R&D focus includes oncology new drugs, ARV drugs from plants, and COVID-19 therapeutics, with over 600 formulation products serving 354,000 doctors across 80+ markets.

Differentiator

Problem solved

Functional benefit

Brands

• Bliss Division: Division focused on patient education and healthcare awareness, recognized in India Book of Records for World Nutrition Month initiative.
• Dermaglow
• ASRA Division
• AURA Division
• Diaspa Division
• Volga Division
• ULTRA Division
• bbold
• DaSutra
• Vidhita
• Radiance

Products and services

• Silero Film Lactic acid vaginal film for treating vaginal dryness and itching by restoring healthy vaginal pH balance. Features bio-adhesive polymers for longer adherence.
• Secnia Capsule Plant-based oral probiotic for Indian women containing four strains of Lactobacilli that maintains healthy vaginal microflora, prevents vaginal infections, and relieves vaginal distress.
• Mylotin Tablets PCOS supplement containing Myo-Inositol, D-Chiro inositol, Chromium Picolinate, Folic acid, Melatonin, and Vitamin D3 for hormonal balance and fertility support.
• Feminora Gel Sperm-friendly vaginal lubricant gel for vaginal dryness in reproductive age group patients. Supports sperm motility and provides antioxidant support to sperm.
• Dydropal 10mg Tablets Dydrogesterone 10mg tablets for supplementing progesterone deficiency in conditions like female infertility, menstrual cramps, PMS, endometriosis, and miscarriage prevention.
• Mesarem 2g Pellets Mesalazine pellets for treatment of mild to moderate ulcerative colitis. First-line anti-inflammatory medication for induction and maintenance of remission.
• Pazinib 400mg Tablets Pazopanib Hydrochloride 400mg tyrosine kinase inhibitor for first-line treatment of advanced renal cell carcinoma and soft-tissue sarcoma.
• Ninlib Capsules 150mg Nilotinib capsules for treatment of Philadelphia chromosome positive chronic myeloid leukemia in adult and pediatric patients.
• Dyronib 70mg Tablet Dasatinib 70mg for treatment of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.
• Ulfree Gel Topical oral gel containing Lignocaine Hydrochloride 2%, Choline Salicylate 8.7%, and Benzalkonium Chloride 0.01% for treatment of mouth ulcers.
• Dasutra X50 Tablets Sildenafil 50mg tablets for erectile dysfunction, enhancing blood circulation to the penis for firmer and sustained erections.
• Pronocte Advanced Health Supplement Nocturnal supplementation for sarcopenia in patients with liver cirrhosis containing Brown Rice Protein, MCT, and essential amino acids for muscle preservation.
• SZN 500 Tablets Sulfasalazine 500mg gastro-resistant tablets for treatment of rheumatoid arthritis, reducing inflammatory markers and inhibiting folate metabolism.
• Prutis 150mg Capsules Nintedanib soft gelatin capsules 150mg for treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated ILD, and chronic fibrosing ILDs.
• Mycotero Sodium 360mg Tablet Mycophenolate Sodium enteric-coated tablets for prophylaxis of organ rejection in kidney transplant patients.
• Maball-RA 500mg Injection Rituximab 500mg/50ml injection for treatment of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, and Granulomatosis with Polyangiitis.
• Jogren 60 Tablets Pilocarpine Hydrochloride 5mg tablets for treatment of dry mouth and dry eyes in patients with Sjogren's syndrome.
• Iguvic 25mg Tablets Iguratimod 25mg for treatment of active rheumatoid arthritis symptoms, inhibiting NF-kB activity and inflammatory cytokine generation.
• HETQ 400mg Tablet Hydroxychloroquine 400mg for prevention and treatment of malaria, chronic discoid lupus erythematosus, and rheumatoid arthritis.
• PEB-MB6 Oral Solution Potassium citrate, magnesium citrate and Vitamin B6 oral solution for management of renal calculi and gout, preventing kidney stone formation.
• Da Sutra 30X Tablet Combination of Sildenafil 50mg and Dapoxetine 30mg for treatment of premature ejaculation and erectile dysfunction, delaying ejaculation by 3-4 fold.
• Prega End Kit Medical termination kit containing Mifepristone 200mg and Misoprostol 200mcg for safe, non-surgical early pregnancy termination.
• bbold Women's Wellness Brand Women's wellness and personal care brand offering menstrual cups, menstrual discs, intimate wash, menstrual cramp relief patches, and dissolvable microneedle acne patches.
• DaSutra Condoms Sexual wellness condom brand including Dotted, Max Pleasure, Ultra Thin, Wet & Wild, and XTRATIME variants.
• JeeraFAST Natural antacid powder with real Jeera (cumin) for instant acidity and gas relief, suitable for daily use.
• Menthopas Pain Relief Patches Topical pain relief patches for muscle and joint pain management.
• Covifor 100mg Injection COVID-19 management product, remdesivir injection for treatment of hospitalized COVID-19 patients.
• Movfor 200mg Capsules Molnupiravir capsules for COVID-19 management, oral antiviral treatment.
• MinoStrong Dermatology brand from Dermaglow Division showcased at Roots IX Conference 2026.
• Tofus Dermatology brand from Dermaglow Division showcased at Roots IX Conference 2026.
• Moiste Moisturizer product from Dermaglow Division, showcased at Roots IX Conference 2026.
• Pharmaceutical Formulation Development Services R&D services including formulations development, scale-up batches, bio-studies, clinical studies, stability testing, validation, regulatory support, packaging design and development, and commercial production for domestic and international markets.

Quantifiable outcome

• 2.3 billion medicine and vaccine doses produced and delivered in 2023
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Catalyst PharmaceuticalsminorOthers · 7 May 2026Settlement in patent litigation resolved between Catalyst Pharmaceuticals and Hetero USA as part of Angelini Pharma's acquisition of Catalyst. The litigation involving Hetero USA over Fycompa was settled as part of the deal resolution.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Lupin Limited: Indian generic major with strong field-force reach and overlapping portfolios in cardiology, anti-infectives, and women's health. Comparable India-led GTM and emerging-markets expansion.
• Sun Pharma: India's largest pharma company by revenue with a broad specialty and generics portfolio including dermatology, oncology, and rheumatology — directly overlapping Hetero's Dermaglow, ASRA, and oncology divisions.
• Torrent Pharmaceuticals: Indian pharma company with overlapping therapeutic focus in cardiology, diabetology, and women's health, plus comparable India field-force distribution model.
• Mankind Pharma: Large Indian pharma company competing head-on in OTC (sexual wellness, antacids), chronic therapy, and consumer wellness — directly overlapping Hetero's Ultra Division and bbold sub-brand.
• Cipla Limited: One of India's largest generic pharmaceutical companies with overlapping therapeutic areas (respiratory, oncology, ARVs, women's health) and a comparable India + emerging markets GTM. Significantly larger and publicly listed.
• Alkem Laboratories: Indian generic manufacturer with comparable India field-force strength across anti-infectives, gastroenterology, and chronic therapy areas.
• Dr. Reddy's Laboratories: India-based global generic and biosimilars player with overlapping oncology, gastroenterology, and women's health portfolios, plus comparable US/international patent-litigation exposure.
• Hetero Labs Limited: Sister/parent entity within the Hetero Group and one of India's largest API and generic finished-dose manufacturers. Directly comparable in therapeutic coverage (ARVs, oncology), but operates at a broader group level with API manufacturing as well.

Emerging players

• Sirona Hygiene: Indian D2C women's wellness brand focused on menstrual cups, intimate hygiene, and feminine care — directly comparable to Hetero's bbold sub-brand on product and target consumer.

Regional players

• Emcure Pharmaceuticals: Indian pharma manufacturer with comparable portfolio in women's health, oncology, and chronic therapy and a similar India-anchored GTM; useful as a regional mid-cap comparable.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/heterohcl

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hetero Healthcare